Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGFA Protein (AA 27-190)

VEGFA Origine: Rat Hôte: HEK-293 Cells Recombinant > 95 % , as determined by Coomassie stained SDS-PAGE. FACS Active
N° du produit ABIN2666576
  • Antigène Voir toutes VEGFA Protéines
    VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
    Type de proteíne
    Recombinant
    Activité biologique
    Active
    Attributs du protein
    AA 27-190
    Origine
    • 20
    • 18
    • 13
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Rat
    Source
    • 36
    • 16
    • 12
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    HEK-293 Cells
    Application
    Flow Cytometry (FACS)
    Pureté
    > 95 % , as determined by Coomassie stained SDS-PAGE.
    Stérilité
    0.22 μm filtered
    niveau d'endotoxine

    Less than 0.01 ng per μg cytokine as determined by the LAL method.

    Top Product
    Discover our top product VEGFA Protéine
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Commentaires

    Biological activity: ED50 = 0.6 - 3.6 ng/mL, corresponding to a specific activity of 0.27 - 1.67 x 106 units/mg, as determined by induction of HUVEC cell proliferation in a dose-dependent manner.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Reconstitution
    For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20 °C to -70 °C. Stock solutions can also be prepared at 50 - 100 μg/mL in sterile buffer (PBS, HPBS, DPBS, or EBSS) containing carrier protein such as 0.2 - 1 % BSA or HSA and stored in working aliquots at -20 °C to -70 °C.
    Buffer
    0.22 μm filtered protein solution is in 5 mM citric acid, 5 mM NaHPO4, 0.15 M NaCl, pH 4.0.
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    Unopened vial can be stored between 2°C and 8°C for one month, at -20°C for six months, or at -70°C for one year.
  • Antigène
    VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
    Autre désignation
    VEGF-164 (VEGFA Produits)
    Synonymes
    MVCD1 Protein, VEGF Protein, VPF Protein, Vegf Protein, Vegf120 Protein, Vegf164 Protein, Vegf188 Protein, Vpf Protein, vegf Protein, vegfa Protein, wu:fj82c06 Protein, VEGF-A Protein, VEGF164 Protein, eVEGF120 Protein, eVEGF164 Protein, vegf-a Protein, vpf Protein, vefg Protein, si:dkey-14d8.3 Protein, wu:fd42e02 Protein, vascular endothelial growth factor A Protein, vascular endothelial growth factor Aa Protein, vascular endothelial growth factor A L homeolog Protein, vascular endothelial growth factor Ab Protein, VEGFA Protein, Vegfa Protein, vegfaa Protein, vegfa.L Protein, vegfa Protein, vegfab Protein
    Sujet
    The VEGF family includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, and placental growth factor (PlGF). VEGF-A is generated as multiple isoforms by alternative splicing. These isoforms are generically identified as VEGFxxx where xxx refers to the number of amino acids. Rat isoforms include VEGF-120, VEGF-164, and VEGF-188. The VEGF gene is highly conserved among human, dog, cow, mouse, rat, pig, and chicken. VEGF164 plays a critical role in new blood vessel formation in vivo. VEGF164 induces angiogenesis on different levels. It acts as mitogen especially on endothelial cells, raises the vessel permeability and dilatation by releasing NO, and has chemotactic impact on monocytes/macrophages which plays a crucial role in inducing inflammatory neovascularization. Angiogenic activities of VEGFs are mediated primarily through the two receptors VEGFR-1 and VEGFR-2. VEGFR-2 signaling is enhanced by interactions with co-receptors such as heparin/heparan sulfate and Neuropilin 1. VEGF induces osteoclast migration and activation. In addition, it supports the survival of mature osteoclasts. These processes play a key role in repairing and remodeling during bone development.
    Poids moléculaire
    The 164 amino acid recombinant protein has a predicted molecular mass of approximately 19.2 kDa. The protein migrates approximately at 25 kDa in DTT-reducing conditions and at approximately 50 kDa in non-reducing conditions by SDS-PAGE. The predicted N-te
    Pathways
    Signalisation RTK, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Vous êtes ici:
Support technique